Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocugen

1.34
+0.01000.75%
Post-market: 1.33-0.0100-0.75%19:53 EST
Volume:2.07M
Turnover:2.75M
Market Cap:418.51M
PE:-6.15
High:1.35
Open:1.34
Low:1.31
Close:1.33
52wk High:1.90
52wk Low:0.5150
Shares:312.32M
Float Shares:306.73M
Volume Ratio:0.48
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2179
EPS(LYR):-0.1995
ROE:-289.93%
ROA:-63.67%
PB:118.46
PE(LYR):-6.72

Loading ...

Ocugen Inc - on Sept 16, Carisma Terminates Merger Agreement With Ocugen - SEC Filing

THOMSON REUTERS
·
Sep 18

Ocugen Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Sep 17

Ocugen’s Strategic Advancements and Promising Prospects Justify Buy Rating

TIPRANKS
·
Sep 17

Ocugen Signs Exclusive License Agreement with Kwangdong

TIPRANKS
·
Sep 16

Why Ocugen Stock Zoomed 12% Higher Today

Motley Fool
·
Sep 16

Ocugen Inc. Stock Advances 12.1%, Outperforms Market

Dow Jones
·
Sep 16

Ocugen Shares up 10.8% After Licensing Deal for Ophthalmic Gene Therapy in South Korea

THOMSON REUTERS
·
Sep 15

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Ocugen, Union Pacific

Reuters
·
Sep 15

Ocugen Inc. and Kwangdong Pharmaceutical Finalize $7.5 Million License Agreement for OCU400 Gene Therapy in Korea

Reuters
·
Sep 15

Ocugen Inc - to GET Royalties Equaling 25% of Net Sales of Ocu400 Generated by Kwangdong

THOMSON REUTERS
·
Sep 15

Ocugen Inc - Upfront Fees and Milestone Payments Totaling up to $7.5 Mln

THOMSON REUTERS
·
Sep 15

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of Ocu400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

THOMSON REUTERS
·
Sep 15

Ocugen Inc - Under Deal, Potential Sales Milestones of $180 Mln in First 10 Years

THOMSON REUTERS
·
Sep 15

Ocugen Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Sep 12

Ocugen Inc. Finalizes Merger Agreement with Carisma Therapeutics, Inc., Including a $5 Million Investment in Common Stock

Reuters
·
Sep 06

Ocugen Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Sep 05

Ocugen Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 04

Ocugen Inc. to Participate in H.C. Wainwright Global Investment Conference in New York

Reuters
·
Sep 02

Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket

Benzinga
·
Sep 02

Ocugen Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 30